CHINA PHARMA HOLDINGS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
China Pharma Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2011 to Q3 2024.
  • China Pharma Holdings, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$32.7K, a 49% increase year-over-year.
  • China Pharma Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$327K, a 22.9% increase from 2022.
  • China Pharma Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$424K, a 21.4% increase from 2021.
  • China Pharma Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was -$539K, a 86.8% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$32.7K +$31.4K +49% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$46.6K +$90.1K +65.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q4 2023 -$327K -$47.7K +$47.5K +49.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$374K -$64.1K +$38.1K +37.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$413K -$137K -$27.9K -25.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$385K -$78.5K +$39.3K +33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$424K -$95.2K +$237K +71.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$661K -$102K -$37.9K -58.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$623K -$109K -$37K -51.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$586K -$118K -$46.9K -66.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$539K -$332K -$224K -209% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$314K -$64.3K -$6.86K -12% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$308K -$71.8K -$9.88K -16% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$298K -$70.9K -$9.24K -15% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$288K -$108K -$37.8K -54.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$251K -$57.4K -$1.65K -2.96% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$249K -$61.9K +$23.2K +27.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$272K -$61.6K +$21.9K +26.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$294K -$69.8K +$9.53K +12% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$304K -$55.8K +$29.8K +34.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$334K -$85.1K +$35.9K +29.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$369K -$83.5K +$43.3K +34.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$413K -$79.3K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$85.6K +$23.3K +21.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$121K +$4.83K +3.84% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$127K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q3 2017 -$109K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$126K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q4 2012 -$303K -$71K -$2.21K -3.22% Oct 1, 2012 Dec 31, 2012 10-K 2013-03-14
Q3 2012 -$301K -$77.9K -$16.7K -27.3% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-14
Q2 2012 -$284K -$77.7K -$276K -139% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-14
Q1 2012 -$8.82K -$76.8K -$695K -112% Jan 1, 2012 Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $686K -$68.8K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$61.2K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 $198K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 $618K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.